DS 3801
Alternative Names: DS-3801; DS-3801bLatest Information Update: 14 May 2016
At a glance
- Originator Daiichi Sankyo Company
- Class Small molecules
- Mechanism of Action Motilin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Constipation
Most Recent Events
- 01 Jul 2014 Phase-I clinical trials in Constipation in Japan (unspecified route)